Shares of ResMed Inc. RMD rallied 1.54% to $237.74 Tuesday, on what proved to be an all-around favorable trading session for ...

With all eyes on Trump's Tariffs this year, one ASX stock may be lucky enough to get a tariff exemption, paving the way for ...

ResMed's largely in-line third quarter results showcased a rising gross margin, while management also moved to ease market ...

Resmed says that U.S. Customs and Border Protection has confirmed that its devices will continue to be exempt from tariffs ...

An update from Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( ($AU:RMD) ) is now available. ResMed Inc. has filed its ...

Resmed shares remained unmoved after hours today on third-quarter results that came in ahead of the consensus forecast.

Does the broker see value in this blue chip? Let's find out. The post What does Macquarie think ResMed shares are worth?

Analysts have provided ResMed with 5 ratings, resulting in a consensus rating of Outperform. The average one-year price ...

Australian sleep health giant Resmed has locked down an exemption from Donald Trump’s sweeping trade tariffs. Resmed produces ...

ResMed dominates healthcare devices with innovation, recurring revenues, and market leadership. See why we believe RMD stock ...

Piper Sandler lowered the firm’s price target on ResMed (RMD) to $248 from $260 and keeps a Neutral rating on the shares. The firm notes the ...

KeyBanc analyst Brett Fishbin raised the firm’s price target on ResMed (RMD) to $274 from $269 on higher estimates, while keeping an Overweight ...